Amerise Biosciences has announced the closure of the trading window for its securities. This restriction will be in effect until 48 hours after the company declares its audited financial results for the quarter and year ended March 31. This move is a common practice to prevent insider trading, ensuring a fair market for all investors. The company will inform stakeholders about the date for its board meeting, where these financial results will be reviewed, at a later time.